Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Predictors of myocardial infarction after an acute coronary syndrome with clopidogrel and prasugrel.

Lalor N, Conde D, Rodriguez L, Elissamburu P, Trivi M.

Am J Emerg Med. 2013 Aug;31(8):1287-8. doi: 10.1016/j.ajem.2013.05.037. No abstract available.

PMID:
23806726
2.

Will prasugrel supersede clopidogrel for acute coronary syndromes?

Hankey GJ, Eikelboom JW, Langton PE.

Med J Aust. 2008 Apr 7;188(7):381-2. Review. No abstract available.

PMID:
18393737
3.

[Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].

Silber S, Helms TM, Garlichs C, Arntz HR, Weil J, Ince H, Klingenheben T, Hoffmann S, Boudriot E, Steiger H, Zugck C.

Dtsch Med Wochenschr. 2011 Apr;136(15):782-5. doi: 10.1055/s-0031-1272567. Review. German. No abstract available.

PMID:
21432747
4.

Prasugrel: Clinical development and therapeutic application.

Guerra DR, Tcheng JE.

Adv Ther. 2009 Nov;26(11):999-1011. doi: 10.1007/s12325-009-0081-y. Review.

PMID:
20020231
5.

Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients.

Tcheng JE, Mackay SM.

Am J Cardiovasc Drugs. 2012 Apr 1;12(2):83-91. doi: 10.2165/11594600-000000000-00000. Review.

PMID:
22316323
6.

Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

Aradi D, Komócsi A, Vorobcsuk A, Serebruany VL.

Thromb Haemost. 2013 Jan;109(1):93-101. doi: 10.1160/TH12-06-0377. Review.

PMID:
23197191
7.

[Platelet inhibition with prasugrel].

Gassanov N, Caglayan E, Nia AM, Erdmann E, Er F.

Dtsch Med Wochenschr. 2010 Aug;135(31-32):1542-6. doi: 10.1055/s-0030-1262444. Review. German.

PMID:
20665417
8.

Prasugrel: a critical comparison with clopidogrel.

Reinhart KM, White CM, Baker WL.

Pharmacotherapy. 2009 Dec;29(12):1441-51. doi: 10.1592/phco.29.12.1441. Review.

PMID:
19947804
9.

Efficacy and safety of prasugrel in acute coronary syndrome patients.

Nanau RM, Delzor F, Neuman MG.

Clin Biochem. 2014 May;47(7-8):516-28. doi: 10.1016/j.clinbiochem.2014.03.005. Review.

PMID:
24657510
10.

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Norgard NB, Abu-Fadel M.

Vasc Health Risk Manag. 2009;5:873-82. Review.

PMID:
19898643
11.

Is prasugrel more effective than clopidogrel in patients with acute coronary syndrome scheduled for PCI?

Graber MA, Dachs R, Darby-Stewart A.

Am Fam Physician. 2008 Dec 1;78(11):1252-3. Review. No abstract available.

PMID:
19069017
12.

Prasugrel vs. ticagrelor in acute coronary syndromes: which one to choose?

Alber HF, Huber K, Pachinger O, Frick M.

Wien Klin Wochenschr. 2011 Aug;123(15-16):468-76. doi: 10.1007/s00508-011-0027-7. Review.

PMID:
21800048
13.

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention.

Greenhalgh J, Bagust A, Boland A, Saborido CM, Fleeman N, McLeod C, Dundar Y, Dickson R, Proudlove C, Kolamunnage-Dona R, Fisher M.

Health Technol Assess. 2010 May;14 Suppl 1:31-8. doi: 10.3310/hta14Suppl1/05. Review.

PMID:
20507801
14.

[Differentiated antiplatelet therapy for acute coronary syndromes].

Schäfer A, Arntz HR, Boudriot E, Garlichs C, Hoffmann S, Ince H, Klingenheben T, Weil J, Zugck C, Helms TM, Silber S.

Dtsch Med Wochenschr. 2014 Jan;139(4):152-8. doi: 10.1055/s-0033-1359911. Review. German.

PMID:
24430955
15.

Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrel.

Martin MT, Spinler SA, Nutescu EA.

Clin Ther. 2011 Apr;33(4):425-42. doi: 10.1016/j.clinthera.2011.04.007. Review.

PMID:
21635989
16.

Prasugrel (Effient) vs. clopidogrel (Plavix).

[No authors listed]

Med Lett Drugs Ther. 2009 Sep 7;51(1320):69-70. Review.

PMID:
19738549
17.

Prasugrel for the treatment of patients with acute coronary syndrome.

Marzot F, Pengo V.

Vasc Health Risk Manag. 2009;5(1):321-4. Review.

PMID:
19436677
18.

Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Capranzano P, Ferreiro JL, Angiolillo DJ.

Expert Rev Cardiovasc Ther. 2009 Apr;7(4):361-9. doi: 10.1586/erc.09.4. Review.

PMID:
19379060
19.

Pharmacokinetics, drug metabolism, and safety of prasugrel and clopidogrel.

Achar S.

Postgrad Med. 2011 Jan;123(1):73-9. doi: 10.3810/pgm.2011.01.2247. Review.

PMID:
21293086
20.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

Toth PP.

Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955. Review.

PMID:
19179814
Items per page

Supplemental Content

Support Center